Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
ANGO AngioDynamics
13.000+0.140+1.09%
Close
01/26 16:00 ET
13.0000.0000.00%
Pre Mkt Price 01/27 04:00 ET
High
13.280
Open
12.880
Turnover
4.68M
Low
12.795
Pre Close
12.860
Volume
360.01K
Pre-Market
5D
1D
1W
1M
1Q
1Y
Price Forecast
News
Comment
Are Options Traders Betting on a Big Move in AngioDynamics (ANGO) Stock?
Mitsubishi UFJ Kokusai Asset Management Co. Ltd. Cuts Position in AngioDynamics, Inc. (NASDAQ:ANGO)
Mitsubishi UFJ Kokusai Asset Management Co. Ltd. trimmed its position in AngioDynamics, Inc. (NASDAQ:ANGO – Get Rating) by 2.4% during the third quarter, according to the company in its most recent
AngioDynamics, Inc. (NASDAQ:ANGO) Sees Large Growth in Short Interest
AngioDynamics, Inc. (NASDAQ:ANGO – Get Rating) was the recipient of a large increase in short interest in the month of December. As of December 30th, there was short interest totalling 1,440,000 shar
AngioDynamics, Inc. (NASDAQ:ANGO) Stake Raised by Allspring Global Investments Holdings LLC
Allspring Global Investments Holdings LLC grew its holdings in shares of AngioDynamics, Inc. (NASDAQ:ANGO – Get Rating) by 0.9% in the 3rd quarter, according to the company in its most recent filing
AngioDynamics (NASDAQ:ANGO) Price Target Lowered to $22.00 at Raymond James
AngioDynamics (NASDAQ:ANGO – Get Rating) had its price objective lowered by Raymond James from $25.00 to $22.00 in a report released on Friday morning, Benzinga reports. Raymond James currently has a
AngioDynamics Second Quarter 2023 Earnings: Revenues Beat Expectations, EPS Lags
KeyCorp Analysts Lower Earnings Estimates for AngioDynamics, Inc. (NASDAQ:ANGO)
AngioDynamics, Inc. (NASDAQ:ANGO – Get Rating) – Research analysts at KeyCorp cut their FY2024 earnings per share estimates for AngioDynamics in a research note issued on Thursday, January 5th. Ke
AngioDynamics (NASDAQ:ANGO) Releases FY23 Earnings Guidance
AngioDynamics (NASDAQ:ANGO – Get Rating) issued an update on its FY23 earnings guidance on Thursday morning. The company provided earnings per share (EPS) guidance of $0.01-0.06 for the period, compa
AngioDynamics (ANGO) Q2 Earnings, Revenues Top Estimates
Raymond James Adjusts AngioDynamics' Price Target to $22 From $25, Keeps Strong Buy Rating
10:33 AM EST, 01/06/2023 (MT Newswires) -- (MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may co
Company Overview
More
AngioDynamics, Inc. is a medical device company, which engages in the development, manufacture, and sale of medical devices for vascular access, surgery, peripheral vascular disease, and oncology. It offers ablation systems, fluid management systems, vascular access, angiographic, drainage. thrombolytic, and venous products. The company was founded by Eamonn P. Hobbs on February 9, 1988 and is headquartered in Latham, NY.
CEO： Mr. James C. Clemmer
Market： NASDAQ
Listing Date： 05/27/2004
Paper Trade
More
Hot List
TradeSearchNews
SymbolLatest price%Chg
Loading...
Watchlist
No Stock Yet